B+
Bull case
25%
Probability
Target price
$32.00
Analysis reference price unavailable
Analysis 2026-07-17 · RankAlpha Sentiment Codex
KMTS
Kestra MedicalBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Strong revenue growth, improving gross margin, rising prescriptions, and FY27 guidance support continued commercialization upside.
Posture
Constructive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-09-14 · AMC.
What can break
Adjusted EBITDA losses and higher commercial-expansion expenses may delay operating leverage.
Momentum
67
Value
37
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $27.00 · Bull $32.00 · Bear $18.00Analysis 2026-07-17; returns require an exact persisted reference.
Earnings
2026-09-14 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $30.00
Why
Momentum67 · Δ7d -11.8
Value37 · Δ7d -0.0
Sentiment73 · Δ7d +3.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-09-14 · AMC.
- • Sentiment remains the lead driver in the composite, 7D delta +3.7.
Contradictions & invalidation
- • Adjusted EBITDA losses and higher commercial-expansion expenses may delay operating leverage.
- • Execution risk against the $137 million FY27 revenue guide.
- • The company remains loss-making, adjusted EBITDA loss widened to $26.7 million in Q4, and accelerated commercial investment raises execution and financing sensitivity.
Catalyst clock
2026-09-14 · AMC
FY26 results and FY27 revenue guide
Lead driver: Sentiment · See AI snapshot
Momentum
67
9% active weight
Current posture
7d trendSoftening
Δ7d
-11.8
Δ21d
-19.4
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-7.4
Sentiment
73
62% active weight
Current posture
7d trendImproving
Δ7d
+3.7
Δ21d
+12.7
Why this grade
Composite grade B. Momentum 66.9 / Value 36.6 / Sentiment 73.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-17. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$27.00
Analysis reference price unavailable
Analysis 2026-07-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$18.00
Analysis reference price unavailable
Analysis 2026-07-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.63B
Beta
-
Shares Out
58.6M
P/E (TTM) · Derived
-11.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-12.79
Rev YoY
+66.2%
EPS YoY
-37.2%
Gross Margin
+51.4%
Op Margin
-141.6%
Net Debt
-$149.64M
Current Ratio
4.41
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data